In charge of the « Bcl2 and p53 pathway regulation in multiple myeloma and mantle-cell lymphoma » team at CRCINA.
Catherine Pellat is research director at CNRS (National Centre of Scientific research). She has developed and characterised a unique collection of myeloma cell-lines in order to decipher the heterogeneity of myeloma at a molecular level and identify the targets and biomarkers linked to oncogenomic diversity.
Since 2010, she has expanded her expertise to mantle-cell lymphoma and has concentrated her studies on the role of the p53 pathway in the extrinsic and intrinsic pathways of apoptosis in response to chemotherapy, radiotherapy and virotherapy in myeloma and mantle-cell. Since 2017, she has been the leader of the « Bcl2 and p53 pathway regulation in multiple myeloma and mantle cell lymphoma » team at CRCINA.